packageEptinezumab

eptinezumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Eptinezumab is a monoclonal antibody used to prevent migraine attacks. It is an authorised medicine in the European Union and is also approved elsewhere, given as an infusion by healthcare professionals.

Summary written by glm-5.3-flash from Wikidata Q28208949 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:eptinezumab
ATC codes:N02CD05
DrugBank:DB14040
Wikidata:Q28208949
molar mass:143000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown